Abstract:Background Toxic components frequently exhibit unique characteristics and activities, offering ample opportunities for the advancement of anti-cancer medications. As the main hepatotoxic component of Dioscorea bulbifera L. (DB), Diosbulbin B (DIOB) has been widely studied for its anti-tumor activity at nontoxic doses. However, the effectiveness and mechanism of DIOB against non-small cell lung cancer (NSCLC) remains unclear. Purpose To evaluate the anti-NSCLC activity of DIOB and to elucidate the specific mechanism of action. Method The effect of DIOB on NSCLCL in vitro was evaluated through CCK8, colony formation, and flow cytometry. The in vivo efficacy and safety of DIOB in treating NSCLC were assessed using various techniques, including HE staining, tunel staining, immunohistochemistry, and biochemical index detection. To understand the underlying mechanism, cell transfection, western blotting, molecular docking, cellular thermal shift assay (CESTA), and surface plasmon resonance (SPR) were employed for investigation. Results DIOB effectively hindered the progression of NSCLC both in vitro and in vivo settings at a no-observed-adverse-effect concentration (NOAEC) and a safe dosage. Specifically, DIOB induced significant G0/G1 phase arrest and apoptosis in A549, PC-9, and H1299 cells, while also notably inhibiting the growth of subcutaneous tumors in nude mice. Mechanistically, DIOB could directly interact with oncogene Yin Yang 1 (YY1) and inhibit its expression. The reduction in YY1 resulted in the triggering of the tumor suppressor P53, which induced cell cycle arrest and apoptosis in NSCLC cells by inhibiting the expression of Cyclin A2, B2, CDK1, CDK2, CDK4, BCL-2, and inducing the expression of BAX. In NSCLC cells, the induction of G0/G1 phase arrest and apoptosis by DIOB was effectively reversed when YY1 was overexpressed or P53 was knocked down. Importantly, we observed that DIOB exerted the same effect by directly influencing the expression of YY1-regulated c-Myc and BIM, particularly in the absence of P53. Conclusion For the inaugural investigation, this research unveiled the anti-NSCLC impact of DIOB, alongside its fundamental mechanism. DIOB has demonstrated potential as a treatment agent for NSCLC due to its impressive efficacy in countering NSCLC.

Imaging analysis for relationship between anticancer effect of bleomycin A5 and superoxide dismutase activity

Effect of 5-Azn-2'-deoxycytidine on Proliferation of Human Lung Adenocarcinoma Cell Line A549 in Vitro

Radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 human lung adenocarcinoma cells

Study on in Vitro Reversing Multidrug Resistance of Human Breast Cancer Cells by Buthionine Sulfoximine

Effect of Hypoxia on Inducing Apoptosis in Non-small Cell Lung Cancer A549 and Expression of Survivin

Supercritical-Carbon Dioxide Fluid Extract from Chrysanthemum indicum Enhances Anti-Tumor Effect and Reduces Toxicity of Bleomycin in Tumor-Bearing Mice

The Effect of Extracellular Superoxide Dismutase (SOD3) Gene in Lung Cancer

Abstract 4687: Primary study on the anticancer role of BAM15 in lung cancer cells

Deoxidized gulose moiety attenuates the pulmonary toxicity of 6'-deoxy-bleomycin Z without effect on its antitumor activity

Relationship between the effect of docetaxel inducing apoptosis of non-small-cell lung cancer cell and the intracellular level of reactive oxygen

Effect of Superoxide Dismutase and Diethyldi-Thicarbamate on the Induction of Squamous Cell Carcinoma of Lung Withmethyl-Cholanthren in Rats

The anti-non-small cell lung cancer effect of Diosbulbin B: Targeting YY1 induced cell cycle arrest and apoptosis

Survival of Cells with Bleomycin-Induced Chromosomal Lesions in the Cultured Lymphocytes of Lung Cancer Patients

Effect of Dai-Bai-Jie on the Proliferation and Migration of the A549 Cells

Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells.

The Effect of Bleomycin on DNA Damage and H2AX Interacting Proteins in Hepatocellular Carcinoma (HCC) Cells

Polyphosphate Reverses the Toxicity of the Quasi-Enzyme Bleomycin on Alveolar Endothelial Lung Cells In Vitro

Anticancer effect of Limonin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway

Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines

The Effect of Agrimol B on A549 Lung Cancer Cells by Blocking Mitochondria Biogenesis

[The Effect of Baicalein on Bleomycin-Induced Fibrosis in Lungs of Rats].